High expression of C1R/C3 is associated with high pathological grade (Figure S7B, Supporting Information) and poor prognosis in PAAD, COAD, and lung cancer patients (Figure S7C, Supporting Information). This evidence concerns the gene C1R and pancreatic adenocarcinoma.